Additional Information
Market: OTCBB
Sector: Medical
EPIC: QMDT
1 year chart
1 day chart
Quick-Med Technologies
www.quickmedtech.com

Quick-Med Technologies is a life sciences company focused on developing broad-based technologies in the medical, consumer, healthcare and industrial markets.

Quick-Med Technologies Granted Fourth Patent For NIMBUS Products

8th Sep 2010, 8:25 pm
Quick-Med Technologies Granted Fourth Patent For NIMBUS Products

Florida-based life sciences company Quick-Med Technologies (OTCBB:QMDT) has said today that the U.S. patent office has granted the company another patent for the process associated with its NIMBUS technology used to treat wounds.

NIMBUS is a wound dressing with non-leaching antimicrobial and is non-toxic. The dressings serve as a barrier to infection, killing germs absorbed into the dressing, while not interfering with tissue healing.

The patent, which is the fourth patent secured by Quick-Med for its NIMBUS technology, protects the process used to bind the active agent to wound dressings and other substrates, said the company.

The other three patents cover applications to a broad range of substrates including textiles, medical products, filters, and packaging composed by cellulosics.

Quick-Med Technologies is focused on developing proprietary, broad-based technologies for infection prevention and control in the consumer and healthcare markets.

The company commercialized its NIMBUS technology in traditional wound care products in 2009 and is now developing NIMBUS applications in several advanced wound dressing formats including adhesives, foams, hydrogels, films, and hydrocolloids.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.